Stand Up to Cancer awards $73.6 million for novel, groundbreaking cance...(here it can benefit patients as quickly ...),Health

Date:5/27/2009

here it can benefit patients as quickly as possible. SU2C's distinctive funding model was specifically designed to eliminate barriers that can inhibit creativity and collaboration, in part, by enabling scientists with different expertise from different institutions across the country and in some cases, internationally to work together. The five Dream Teams are comprised of 7 leaders, 4 co-leaders and 27 principal researchers from over 20 leading institutions, with more than 300 individuals participating in total. Each team will have at least two members from patient advocacy groups to ensure that the perspective of the patients and survivors they represent will be integrated into the research on an ongoing basis.

The teams are listed below in alphabetical order according to the name of the leaders, and they will pursue the following important topics (full list of team members ATTACHED):

• "Bringing Epigenetic Therapy to the Forefront of Cancer Management" / Leader: Stephen B. Baylin, M.D., Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Co-Leader: Peter A. Jones, Ph.D., Distinguished Professor of Urology and Biochemistry & Molecular Biology, University of Southern California;

• "Targeting the PI3K Pathway in Women's Cancers" / Leader: Lewis C. Cantley, Ph.D., Chief of the Division of Signal Transduction at Beth Israel Deaconess Medical Center; Co-Leaders: Charles L. Sawyers, M.D., Director of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center, and Gordon B. Mills, M.D., Ph.D., Chair, Department of Systems Biology, University of Texas M. D. Anderson Cancer Center;

• "An Integrated Approach to Targeting Molecular Breast Cancer Molecular Subtypes and Their "Resistance" Phenotypes" / Leaders: Joe W. Gray, Ph.D., Life Sciences Division Director, Lawrence Berkeley National Laboratory, and Dennis J. Slamon, M.D., Ph.D., Director of Clinical/Translatio
  '/>"/>

Contact: Jeremy Moore jeremy.moore@aacr.org 609-519-0212 American Association for Cancer Research Source:Eurekalert

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
2. Thumbs Up at ARVO for Diaton Tonometer - New Through Eyelid Glaucoma Test Clinical Study Presented, Results as Accurate as Gold Standard
3. HCAs Perlin Named Chair of HHS Health IT Standards Committee
4. Prestigious award for outstanding primary-care researcher
5. Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes
6. New Educational Tool for Understanding UC Flares
7. PRN Calls on Obama Lawyers to Stand Down in Their Drug War on Patients and Doctors
8. AIBS honors outstanding contributions to biology
9. SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards
10. Standard & Poors Announces Changes to U.S. Index
11. NYSE Amex Accepts Interleukin Genetics Plan to Meet Continued Listing Standards